BSE   22 May 13 | 12:00 AM 1644.05 -39.75 (-2.36%) Mkt Price (Rs)   Chg Rs (Chg %) Code: 532300 Face Value: 5

NSE   22 May 13 | 12:00 AM 1642.25 -41.55 (-2.47%) Mkt Price (Rs)   Chg Rs (Chg %) Code: WOCKPHARMA

Performance 1 Week : Rs 1,828.75 (-10.10%) 1 Month : Rs 1,816.35 (-9.49%) 1 Year : Rs 717.75 (129.06%)

Smart Charts | Add to my portfolio | Derivative

News 17 Apr 13 15:15 Wockhardt rebounds on stake hike by FIIs 15 Apr 13 13:15 Wockhardt extends fall on buzz of FDA probe 12 Apr 13 15:17 Wockhardt slumps 10% on heavy volumes 20 Mar 13 00:50 Wockhardt set to join billion-dollar club 04 Dec 12 13:59 US, Europe to be focus markets for future growth: Wockhardt 30 Nov 12 14:27 Wockhardt dips as stock retains in T2T group

Stock Summary

Shareholding Pattern Promoters 73.54 % Mutual Funds / UTI 1.03 % FI/Bank 2.06 % Insurance 0.16 % Others 0.00 % Govt 0.00 % FII 9.07 % Non-Institutions 14.00 % Depository Receipts 0.14 % Total 100.00 %

Key Financials (Rs cr) Dec 2012 Dec 2011 YOY Operating Income 1,435.04 1,140.90 25.78 Total Expenses 910.69 819.64 11.11 Operating Profit 524.35 321.26 63.22 Other Income 24.57 22.39 9.74 PBDIT 548.92 343.65 59.73 PBT 482.62 249.80 93.20 Adjusted Net Profit 417.25 222.50 87.53

Peer Group Company Last (Rs) Chg (%) Mkt Cap (Rs cr) Glaxosmit Pharma 2,277.45 0.07 19,291 Ranbaxy Labs. 431.10 -1.20 18,236 Cadila Health. 786.55 -0.20 16,104 Glenmark Pharma. 563.00 -1.87 15,249 Divi`s Lab. 994.65 -1.28 13,202

Funds Owning this Stock Scheme Name Value (Rs cr) IDFC Sterling Equity Fund (G) 66.17 IDFC Sterling Equity Fund - Direct (G) 62.91 L&T Equity Fund (G) 5.96 Taurus Starshare (G) 2.10 SBI Tax Advantage Fund - Series I (G) 24.26

Announcements

Research Reports Date Broker Action Price (Rs) Report 04/08 Angel Broking Sell 145 04/05 Angel Broking Neutral 88 30/07 Angel Broking Buy 192 30/04 Angel Broking Buy 297